Board of Directors

Tetsuya Mishima President and CEO
Yuji Yamada, Ph.D. Director
Nobutake Morii Director
Takehiko Sawabe Director

Tetsuya Mishima, President and CEO

Mishima serves as President and CEO of the company. He is currently also a partner of Watervein Partners, a venture capital firm, which he co-founded in 2002. Prior to founding Watervein, he was involved in M&A advisory business at Bank of America Investment Banking. Prior to Bank of America, he served as a manager in pharmaceutical business at Asahi Glass. He received a B.S. and an M.S. in Polymer Science at Tokyo Institute of Technology.

Yuji Yamada, Ph.D., Director

Yamada serves as Director of the company. Prior to Anaeropharma, he was Director at Taiho Pharmaceutical, where he was leading many research/development projects in the oncology area. He received a M.S. in Biology from Tohoku University and Ph.D. from Hokkaido University School of Medicine.

Nobutake Morii, Director

Morii serves as Director of the company, and is Vice President of Innovation Network Corporation of Japan, a Japanese government backed venture capital firm. Prior to INCJ, he worked for Equity Research and Investment Banking at Citigroup Securities and Accenture. He received a B.S. in Business Administration from Kobe University.

Takehiko Sawabe, Director

Sawabe serves as Director of the company, and is Vice President of Innovation Network Corporation of Japan, a Japanese government backed venture capital firm. Prior to INCJ, he worked with AbbVie, Johnson & Johnson and Meiji Seika Pharma. He received a M.S. in Pharmaceutical Science from the University of Tokyo.